INFANT TYPE HEMISPHERIC GLIOMA

Clinical trials for INFANT TYPE HEMISPHERIC GLIOMA explained in plain language.

Never miss a new study

Get alerted when new INFANT TYPE HEMISPHERIC GLIOMA trials appear

Sign up with your email to follow new studies for INFANT TYPE HEMISPHERIC GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Targeted drug trial offers hope for children with aggressive brain cancer

Disease control Recruiting now

This study is testing a targeted drug called lorlatinib in children and young adults (ages 1-21) newly diagnosed with aggressive brain tumors (high-grade gliomas) that have specific genetic changes called ALK or ROS1 fusions. The main goals are to see if the drug can control the …

Matched conditions: INFANT TYPE HEMISPHERIC GLIOMA

Phase: EARLY_PHASE1 • Sponsor: Nationwide Children's Hospital • Aim: Disease control

Last updated Mar 27, 2026 12:37 UTC

INFANT TYPE HEMISPHERIC GLIOMA

Get alerted when new INFANT TYPE HEMISPHERIC GLIOMA trials appear

Targeted drug trial offers hope for children with aggressive brain cancer